novartis glp-1 receptor agonist weight management diabetes treatments of type 2 with the dual GIP/GLP-1 tirzepatide: a systematic review and meta-analysis | Diabetologia GLP-1 Receptor Agonists for Weight

In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the ...

78.64.4 l/min/gkw, sodium excretion 7.40.8 vs

Allulose is a rare sugar that may modestly support GLP-1 secretion through gut hormone pathways, but dietary changes alone rarely match the effect of prescription GLP-1 therapy

Here the authors report that D-allulose triggers GLP-1 release in the gut and GLP-1R signaling on vagal afferents, counteracting arrhythmic overeating, obesity and diabetes.

That means it needs strict temperature control, precise manufacturing, and no contamination

Across studies, fat mass decline predominated, whereas reductions in lean body mass were modest